Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Biopharma's Technology Could Render Drug Suitable for COVID-19 Treatment

How this could be achieved using the proprietary platform of TFF Pharmaceuticals and why it could work are discussed in a ROTH Capital Partners report. In an April 7 research note, ROTH Capital Partners analyst Jonathan Aschoff discussed the potential of app...
Streetwise Reports | April 9, 2020 |

Gold To Continue To Base Below $1320 For Weeks

Our research team, at Technical Traders Ltd., believes Gold will continue to base below $1320 for at least another 3~5 weeks before setting up a momentum price base. Our research suggests general weakness in the US stock market over the next few weeks/months as a Head-n-Should...
Chris Vermeulen | March 20, 2019 |

Watch For +15% Move In Chinese Stocks

Last week we had strong numbers out of China and our research continues to suggest the Chinese stock market could be poised for an upside price rally of at least 15% over the next 30+ days before possibly reaching a peak in June or July 2019. Our Fibonacci predictive modeling ...
Chris Vermeulen | April 8, 2019 |

Ximen Mining ESG Reporting: Kenville Gold Mine Hydrogeology

(Click to watch video) As part of a continued commitment to ESG reporting, Ximen Mining is pleased to share summarized results from a hydrogeology assessment completed for the Company’s 100% owned Kenville Gold Mine project in Nelson, southea...
Featured Submission | July 29, 2021 |

Bitcoin Stalls Near $8100

After an incredible 7+week rally in Bitcoin, from $3700 to above $8000, the current price action is setting up for what may become an extended Pennant/Flag formation with quite a bit of sideways trading ahead. Our researchers believe the past 7+ weeks rally in Bitcoin was ...
Chris Vermeulen | June 5, 2019 |

Dec 19th 2019, Crypto Chartbook – Pre holiday opportunity timing

Pre holiday opportunity timing We pointed out risk, reward and psychological abnormalities of pre holiday trading in our previous chartbook . One always should reduce size for this sort of trading. Taking part if opportunity presents itself in pre holiday trading can be v...
Midas Touch Consulting | December 23, 2019 |

Ballard Power, dynaCERT, NEL ASA - where else is it worth investing?

For investors, rising share prices are a confirmation of a successful investment decision. However, experienced market participants also know that from time to time it makes sense to take chips off the table - in other words, to realize profits. It is both important and diffic...
Mario Hose | February 13, 2020 |

Burcon Nutrascience, Enthusiast Gaming, EXMceuticals - Investing in the future

Innovative technologies and social trends often determine the positive performance of an investment portfolio. The biggest challenge, however, is to recognize the development of a new need in society at the right time and to benefit from it with the right companies. But unders...
Mario Hose | April 28, 2020 |

BioNTech, Bayer, Valeo Pharma: Share price jump ahead of quarterly results

Investors' expectations of developments can drive the share price. When it comes to solving a problem or creating needs, the interest of the capital market is particularly high. Things get exciting for investors when the business model offers the possibilities of scalability. ...
Mario Hose | September 29, 2020 |

CureVac, BioNTech, Valeo Pharma: Where is there still potential?

The race for vaccines against Covid-19 is fierce. Every day there are new water level reports - from setbacks to breakthroughs, everything is there. The Tübingen-based Company CureVac ( NASDAQ: CVAC ) recently started its phase study IIa in Peru and Panama. Around 700 people...
Nico Popp | October 16, 2020 |
1 2 3 4 5 6 7 8 9 10 ...